ArticleBMC medicine2022

Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer.

Weihua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.